Development of tumor targeting bioprobes (111In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy

Sally J. DeNardo, Gerald L Denardo, Laird A. Miers, Arutselvan Natarajan, Alan R. Foreman, Cordula Gruettner, Grete N. Adamson, Robert Ivkov

Research output: Contribution to journalArticlepeer-review

178 Scopus citations

Fingerprint

Dive into the research topics of 'Development of tumor targeting bioprobes (111In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences